Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Mar;30(3):585–589. doi: 10.1128/jcm.30.3.585-589.1992

Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides.

A L Barry 1, L B Reller 1, G H Miller 1, J A Washington 1, F D Schoenknect 1, L R Peterson 1, R S Hare 1, C Knapp 1
PMCID: PMC265114  PMID: 1551973

Abstract

A multilaboratory study was undertaken to reassess the amount of calcium and magnesium that should be added to Mueller-Hinton broth when testing Pseudomonas aeruginosa against amikacin, gentamicin, isepamicin, netilmicin, and tobramycin. To achieve parity with agar dilution tests, cation-adjusted broth should contain 20 to 25 mg of calcium and 10 to 12.5 mg of magnesium per liter rather than the 50- and 25-mg/liter supplements recommended previously. For quality control of tests with contemporary media, MIC control limits should be adjusted by lowering the current MIC limits by at least 1 doubling-dilution interval.

Full text

PDF
585

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Miller G. H., Hare R. S., Thornsberry C., Jones R. N. Netilmicin disk susceptibility tests: effect of cations on the MIC correlates. Eur J Clin Microbiol. 1987 Aug;6(4):416–417. doi: 10.1007/BF02013098. [DOI] [PubMed] [Google Scholar]
  2. Barry A. L., Miller G. H., Thornsberry C., Hare R. S., Jones R. N., Lorber R. R., Ferraresi R., Cramer C. Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo. Antimicrob Agents Chemother. 1987 Oct;31(10):1514–1518. doi: 10.1128/aac.31.10.1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kenny M. A., Pollock H. M., Minshew B. H., Casillas E., Schoenknecht F. D. Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin. Antimicrob Agents Chemother. 1980 Jan;17(1):55–62. doi: 10.1128/aac.17.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Pollock H. M., Barry A. L., Gavan T. L., Fuchs P. C., Hansen S., Thornsberry C. L., Frankel H., Forsythe S. B. Selection of a reference lot of Mueller-Hinton agar. J Clin Microbiol. 1986 Jul;24(1):1–6. doi: 10.1128/jcm.24.1.1-6.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Reller L. B., Schoenknecht F. D., Kenny M. A., Sherris J. C. Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis. 1974 Nov;130(5):454–463. doi: 10.1093/infdis/130.5.454. [DOI] [PubMed] [Google Scholar]
  6. Washington J. A., 2nd, Snyder R. J., Kohner P. C., Wiltse C. G., Ilstrup D. M., McCall J. T. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J Infect Dis. 1978 Feb;137(2):103–111. doi: 10.1093/infdis/137.2.103. [DOI] [PubMed] [Google Scholar]
  7. Zimelis V. M., Jackson G. G. Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism. J Infect Dis. 1973 Jun;127(6):663–669. doi: 10.1093/infdis/127.6.663. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES